News
ABVX
102.72
+1.17%
1.19
Walleye Capital discloses net short position in Abivax
PUBT · 17h ago
ABVX DEADLINE: The Gross Law Firm Reminds ABIVAX Societe Anonyme Investors of Upcoming Securities Class Action Deadline
PR Newswire · 18h ago
ABVX Investors Have Opportunity to Join Abivax S.A. Fraud Investigation with the Schall Law Firm
PR Newswire · 1d ago
Weekly Report: what happened at ABVX last week (0601-0605)?
Weekly Report · 1d ago
Analysts Offer Insights on Healthcare Companies: Phibro Animal Health (PAHC) and Abivax SA Sponsored ADR (ABVX)
TipRanks · 2d ago
PDT Partners discloses net short position in Abivax shares
PUBT · 5d ago
What's Going On With Abivax Stock On Thursday?
Benzinga · 5d ago
Abivax flags Bank of America stake at 7.70% of shares, 7.48% voting rights
PUBT · 5d ago
Spyre Therapeutics price target raised to $115 from $102 at Deutsche Bank
TipRanks · 5d ago
Top Biotech Gainers: ABVX, CING, DRTS, MMED...
NASDAQ · 6d ago
This Stock Is Up 1,000% Over the Past Year. Is There More Upside Ahead?
NASDAQ · 6d ago
ABVX Investors Have Opportunity to Join Abivax S.A. Fraud Investigation with the Schall Law Firm
Barchart · 6d ago
This Is Why Abivax Stock (ABVX) Is Up Today
TipRanks · 6d ago
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and MaxCyte (MXCT)
TipRanks · 6d ago
Abivax price target lowered to $136 from $176 at Wolfe Research
TipRanks · 6d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 6d ago
Abivax rises 14.1%
TipRanks · 6d ago
D.E. Shaw discloses net short position in Abivax shares
PUBT · 6d ago
Qube Research & Technologies discloses net short position in Abivax shares
PUBT · 6d ago
Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday
Benzinga · 6d ago
More
Webull provides a variety of real-time ABVX stock news. You can receive the latest news about Abivax S.A. through multiple platforms. This information may help you make smarter investment decisions.
About ABVX
Abivax SA is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of anti-viral compounds and therapeutic vaccines against severe and life threatening infectious diseases. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The Company's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.